Oscar Health (NYSE:OSCR) PT Raised to $16.00

Oscar Health (NYSE:OSCRFree Report) had its price target increased by The Goldman Sachs Group from $8.00 to $16.00 in a report released on Friday morning, Benzinga reports. They currently have a neutral rating on the stock.

Separately, Bank of America upgraded shares of Oscar Health from a neutral rating to a buy rating and raised their price target for the stock from $8.00 to $9.00 in a research note on Thursday, November 2nd. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, Oscar Health currently has a consensus rating of Hold and an average price target of $9.40.

Check Out Our Latest Analysis on OSCR

Oscar Health Trading Down 2.0 %

Shares of NYSE OSCR opened at $17.33 on Friday. The business has a 50 day simple moving average of $10.54 and a 200 day simple moving average of $7.91. Oscar Health has a 52 week low of $3.22 and a 52 week high of $17.99. The stock has a market cap of $3.92 billion, a price-to-earnings ratio of -14.44 and a beta of 1.72. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.36 and a current ratio of 1.36.

Oscar Health (NYSE:OSCRGet Free Report) last released its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.74) by $0.08. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 28.95%. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the previous year, the business earned ($1.05) EPS. The business’s revenue was up 43.9% on a year-over-year basis. On average, research analysts predict that Oscar Health will post 0.04 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Alessandrea C. Quane sold 16,793 shares of the stock in a transaction that occurred on Wednesday, December 6th. The shares were sold at an average price of $8.16, for a total value of $137,030.88. Following the transaction, the executive vice president now directly owns 301,223 shares in the company, valued at $2,457,979.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, EVP Alessandrea C. Quane sold 16,793 shares of the company’s stock in a transaction dated Wednesday, December 6th. The stock was sold at an average price of $8.16, for a total value of $137,030.88. Following the completion of the sale, the executive vice president now directly owns 301,223 shares of the company’s stock, valued at approximately $2,457,979.68. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 30,029 shares of Oscar Health stock in a transaction that occurred on Wednesday, December 6th. The stock was sold at an average price of $8.16, for a total transaction of $245,036.64. Following the transaction, the chief financial officer now directly owns 548,613 shares in the company, valued at approximately $4,476,682.08. The disclosure for this sale can be found here. In the last three months, insiders sold 437,227 shares of company stock valued at $3,161,751. 25.54% of the stock is currently owned by insiders.

Institutional Trading of Oscar Health

A number of large investors have recently bought and sold shares of OSCR. Envestnet Asset Management Inc. bought a new stake in Oscar Health during the 1st quarter worth approximately $164,000. Advisor Group Holdings Inc. boosted its position in shares of Oscar Health by 157.5% during the first quarter. Advisor Group Holdings Inc. now owns 10,106 shares of the company’s stock worth $101,000 after buying an additional 6,182 shares during the period. Swiss National Bank boosted its position in shares of Oscar Health by 8.6% during the first quarter. Swiss National Bank now owns 103,100 shares of the company’s stock worth $1,028,000 after buying an additional 8,200 shares during the period. Ergoteles LLC acquired a new position in shares of Oscar Health during the first quarter worth about $633,000. Finally, Charles Schwab Investment Management Inc. lifted its position in Oscar Health by 2.5% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 193,504 shares of the company’s stock worth $1,930,000 after buying an additional 4,801 shares in the last quarter. 66.70% of the stock is owned by institutional investors.

About Oscar Health

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products.

Further Reading

Analyst Recommendations for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.